Background illustration for clinical trials search

Paid Clinical Trials Waterbury

Discover 1,141 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

for
Diabetes Type 2, Overweight or Obesity
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 40+

Code: NCT07376655

Recruiting
Active & Responsive

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

for
Type 1 Diabetes, New Onset
Location: New Haven CT, Buffalo NY, Pittsburgh PA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 9 - 20

Code: NCT07061574

Phase1, Phase2, Recruiting
Active & Responsive

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

for
Type 1 Diabetes Mellitus
Location: New Haven CT, New York NY, Boston MA, Pittsburgh PA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 8 - 45

Code: NCT07142252

Phase2, Recruiting
Active & Responsive

Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma

for
Locally Advanced Urothelial Carcinoma,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07048457

Phase2, Recruiting
Active & Responsive

Investigation of Lymph Node Biology in Kidney Cancer

for
Renal Cell Carcinoma (RCC)
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07038733

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: New Haven CT, New York NY, Boston MA,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07111520

Phase1, Phase2, Recruiting
Active & Responsive

Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder

for
Alcohol Use Disorder
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21 - 65

Code: NCT07029529

Phase2, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: New Haven CT, New York NY, New Brunswick NJ, Boston MA,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: New Haven CT, New York NY, Philadelphia PA,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

Integrated Treatment for Enhancing Growth in Recovery During Adolescence

for
Alcohol Use Disorder, Cannabis Use Disorder
Location: Farmington CT, Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 14 - 21

Code: NCT06395467

Recruiting
Active & Responsive

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

for
Alzheimer Disease
Location: Farmington CT, Springfield MA, New Windsor NY,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT06585787

Phase3, Recruiting
Active & Responsive

Effects of Hard Gum Chewing on Facial Soft Tissue Morphology

for
Face
Location: Farmington CT
Sponsor: UConn Health

Sex: All

Age: 20 - 40

Code: NCT07726511

Recruiting
Active & Responsive

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Farmington CT, Cromwell CT, Mount Kisco NY, New York NY,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT06966401

Phase3, Recruiting
Active & Responsive

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for
Generalized Myasthenia Gravis
Location: Farmington CT, Burlington VT, Washington D.C. DC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06463587

Phase3, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Farmington CT, New York NY, Albany NY, Boston MA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: New Haven CT, Manhasset NY, New York NY, Sparta NJ,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: New Haven CT, Manhasset NY, Ridgewood NJ, New York NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for
Generalized Myasthenia Gravis
Location: New Haven CT, New Hyde Park NY, Boston MA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04202341

Recruiting
Active & Responsive

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for
Relapsed Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Montreal, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07391657

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

for
Bipolar-I Disorder With Mania or Mania With Mixed Features
Location: New Haven CT, Staten Island NY, North Canton OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951698

Phase3, Recruiting